Team:Slovenia
From 2009.igem.org
(Difference between revisions)
Line 29: | Line 29: | ||
==Summary of our main achievements== | ==Summary of our main achievements== | ||
- | + | <html><ul> | |
+ | <li>We designed the <b>self-assembling polyhedra based on combinations of coiled-coil-forming segments</b> as the polypeptide equivalent of DNA origami producing structures that do not exist in nature. We analyzed the topology of possible combinations of coiled-coil-forming segments and for the first time demonstrated the feasibility of this approach on a polypeptide composed of three designed coiled-coil-forming segments. This polypeptide can by slow annealing <b>assemble a box</b> or <b>two-dimensional polypeptide lattice</b>, depending on its concentration. Formation of nanoscale assembly and polypeptide lattice was confirmed by AFM and TEM.</li><br> | ||
- | + | <li>We prepared polypeptide assemblies, based on gyrase B fragment, which can be <b>assembled and disassembled by the addition of different compounds</b>, which has particularly useful properties for drug delivery.</li><br> | |
- | + | <li>We proposed an approach for <b>biomaterial design</b> that could be crosslinked through coiled-coil interactions, which will allow introducing <b>additional functional polypeptides</b> that provide different functions to the cell-growth matrix, such as antimicrobial activity (LL-37 peptide), cell differentiation (NGF), growth factors etc, with an almost unlimited number of potential combinations.</li><br> | |
- | + | <li>We prepared polypeptide network based on self-assembly of a polypeptide that contains a p53 <b>tetramerization domain and a coiled coil domain</b>. <b>Real world application</b> such as <b>ultrafiltration</b> was demonstrated on self-assembled polypeptide membrane for the removal of viruses.</li><br> | |
- | + | <li>We introduced a BioBrick standard variant ([http://dspace.mit.edu/bitstream/handle/1721.1/46705/BBFRFC37.pdf?sequence=1 BBF RFC 37]) that allows <b>modification of the length of the linker between polypeptide building blocks</b> and prepared <b>over 100 new BioBricks</b> comprising different coiled-coil combinations, oligomerizing polypeptide domains and functional domains that are dedicated to the manufacturing of polypeptide nanoassemblies.</li><br> | |
- | + | <li>We introduced a procedure that <b>streamlines and unifies manufacturing of polypeptides</b> which results, in principle independently of their sequence, in high yield polypeptide production in bacteria regardless of their toxicity, sensitivity to proteolysis and minimizes the purification steps.</li><br> | |
+ | </ul><br></html> | ||
+ | ==We would like to express our thanks to our sponsors:== | ||
+ | |||
+ | |||
+ | <html> | ||
+ | <center> | ||
+ | <table border="0" cellspacing="10" cellpadding="10"> | ||
+ | <tr> | ||
+ | <td> | ||
+ | <a href="http://www.ki.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/a/a2/KI.gif" width="200" height="130" /></a><br> | ||
+ | National Institute of Chemistry Slovenia | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.uni-lj.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/f/fd/Ulj.jpg" width="200" height="130" /></a><br> | ||
+ | University of Ljubljana | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.ad-futura.si" target="_blank"><img src="https://static.igem.org/mediawiki/2008/3/38/Adfutura.gif" width="200" height="130" /></a><br> | ||
+ | Ad futura | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> | ||
+ | <a href="http://www.arrs.gov.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/2/21/ARRS.gif" width="120" height="70" /></a><br> | ||
+ | Slovenian Research Agency | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.ajdovscina.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2009/f/f1/Ajdov%C5%A1%C4%8Dina.gif" width="120" height="120" /></a><br> | ||
+ | Občina Ajdovščina | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.krka.si" target="_blank"><img src="https://static.igem.org/mediawiki/2009/1/16/Krka.jpg" width="150" height="65" /></a><br> | ||
+ | KRKA d.d, Novo mesto | ||
+ | </td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> | ||
+ | <a href="http://www.geneart.com/" target="_blank"><img src="https://static.igem.org/mediawiki/2009/4/40/GENEART.gif" width="193" height="42" /></a><br> | ||
+ | GENEART | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.mrgene.com/" target="_blank"><img src="https://static.igem.org/mediawiki/2009/b/bc/MrGene.gif" width="121" height="121" /></a><br> | ||
+ | MrGene | ||
+ | </td> | ||
+ | <td> | ||
+ | <a href="http://www.kemomed.si/" target="_blank"><img src="https://static.igem.org/mediawiki/2008/5/59/Kemomed.jpg" width="80" height="55" /></a><br> | ||
+ | Kemomed d.o.o. | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | <br><br> | ||
+ | MEDILINE d.o.o | ||
+ | </center> | ||
+ | </html> | ||
}} | }} |
Revision as of 01:20, 22 October 2009